| Literature DB >> 23486452 |
Andrew D Zelenetz1, William G Wierda, Jeremy S Abramson, Ranjana H Advani, C Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C Byrd, Myron S Czuczman, Luis E Fayad, Martha J Glenn, Jon P Gockerman, Leo I Gordon, Nancy Lee Harris, Richard T Hoppe, Steven M Horwitz, Christopher R Kelsey, Youn H Kim, Susan Krivacic, Ann S LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M Vose, Joachim Yahalom, Nadeem Zafar, Mary A Dwyer, Maoko Naganuma.
Abstract
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin's Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23486452 DOI： 10.6004/jnccn.2013.0037
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908